Ascent Solar Technologies (ASTI)

Add to Watchlists
Create an Alert
0.0004 +0.00  +0.00% OTC Markets Apr 26, 11:13 Delayed 15m USD

Ascent Solar Technologies Research and Development Expense (Quarterly):

0.9906M for Dec. 31, 2017
View 4,000+ financial data types
View Full Chart

Ascent Solar Technologies Research and Development Expense (Quarterly) Chart

Export Data
Save Image
Print Image

Ascent Solar Technologies Historical Research and Development Expense (Quarterly) Data

View and export this data going back to 2006. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2017 0.9906M
Sept. 30, 2017 1.312M
June 30, 2017 1.241M
March 31, 2017 1.277M
Dec. 31, 2016 1.495M
Sept. 30, 2016 1.660M
June 30, 2016 1.785M
March 31, 2016 1.686M
Dec. 31, 2015 1.609M
Sept. 30, 2015 1.732M
June 30, 2015 1.655M
March 31, 2015 1.716M
Dec. 31, 2014 5.555M
Sept. 30, 2014 5.077M
June 30, 2014 4.342M
March 31, 2014 3.817M
Dec. 31, 2013 5.096M
Sept. 30, 2013 5.336M
June 30, 2013 5.590M
March 31, 2013 5.320M
Dec. 31, 2012 5.778M
Sept. 30, 2012 5.730M
June 30, 2012 4.830M
March 31, 2012 4.390M
Dec. 31, 2011 4.681M
Sept. 30, 2011 4.145M
June 30, 2011 6.701M
March 31, 2011 8.595M
Dec. 31, 2010 7.450M
Sept. 30, 2010 6.418M
June 30, 2010 5.928M
March 31, 2010 4.558M
Dec. 31, 2009 5.090M
Sept. 30, 2009 3.859M
June 30, 2009 3.364M
March 31, 2009 3.196M
Dec. 31, 2008 3.116M
Sept. 30, 2008 2.843M
June 30, 2008 2.227M
March 31, 2008 1.685M
Dec. 31, 2007
Sept. 30, 2007 0.7607M
June 30, 2007 0.6217M
March 31, 2007 0.525M
Dec. 31, 2006
Sept. 30, 2006 0.1035M
June 30, 2006 0.1433M
March 31, 2006 0.0402M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More


ASTI Research and Development Expense (Quarterly) Benchmarks

AXT 1.274M
CEVA 9.972M
DSP 9.09M

ASTI Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 0.9906M Dec 2017
Maximum 5.590M Jun 2013
Average 2.788M

ASTI Research and Development Expense (Quarterly) Excel Add-In Codes

  • Metric Code: r_and_d_expense
  • Latest data point: =YCP("ASTI", "r_and_d_expense")
  • Last 5 data points: =YCS("ASTI", "r_and_d_expense", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.




Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.